新利18娱乐登录|新利18登录不了

Skip to content THE SOURCE Close TopicsTopics Arts & Culture Business & Entrepreneurship Campus & Community Humanities & Society Medicine & Health Science & Technology SchoolsSchools Arts & Sciences Brown School McKelvey School of Engineering Olin Business School Sam Fox School of Design & Visual Arts School of Continuing & Professional Studies School of Law School of Medicine PublicationsPublications Newsroom The Record Washington Magazine Search Menu Search for: Search Close NEWSROOM Sections Find an Expert Media Resources Newsroom Stories Perspectives WashU Experts WashU in the News Mennerick named director of Division of Biology & Biomedical Sciences Psychiatry researcher aims to break down academic silos, enhance student experience Steven Mennerick speaks with graduate student Sarah Koester at Washington University School of Medicine in St. Louis. Mennerick, the John P. Feighner Professor of Neuropsychopharmacology, has been named director and associate dean of the university’s Roy and Diana Vagelos Division of Biology & Biomedical Sciences. (Photo: Matt Miller/School of Medicine) By Tamara Bhandari August 31, 2023 SHARE Neuroscientist Steven Mennerick, a dedicated mentor and the John P. Feighner Professor of Neuropsychopharmacology at Washington University School of Medicine in St. Louis, has been named director and associate dean of the university’s Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS). Mennerick had been serving as the interim associate dean since December 2020 and was named to the permanent position Aug. 1 after a national search. Mennerick also is a professor of psychiatry and of neuroscience, the division director for basic neuroscience in the Department of Psychiatry and scientific director of the Taylor Family Institute for Innovative Psychiatric Research. He studies neuronal signaling with a goal of developing novel medicines for neurological and psychiatric conditions. “Steve has done a wonderful job in the interim role over the past 2 ½ years,” said David H. Perlmutter, MD, the George and Carol Bauer Endowed Dean of the School of Medicine, executive vice chancellor for medical affairs and the Spencer T. and Ann W. Olin Distinguished Professor. “With colleagues, he has spearheaded an innovative, interdisciplinary onboarding experience for incoming PhD students that introduces them to the challenges and rewards of creating new biosciences knowledge. He and his team have successfully grown DBBS’ student numbers by 30% and enhanced the culture of graduate education by increasing career-development opportunities for students and bolstering student organizations. I look forward to supporting him as he continues to move the division forward.” Jointly based in the School of Medicine and in Arts & Sciences, DBBS unites life-science departments across the university to offer unparalleled training and research opportunities for undergraduate and graduate students. DBBS offers support for a growing number of undergraduate summer research and post-baccalaureate pipeline programs. It ranks as one of the best doctoral programs in the country and includes the highly respected Medical Scientist Training Program, which offers students the opportunity to earn medical and doctoral degrees simultaneously. Graduate students can choose from 12 doctoral training programs, including cancer biology, immunology, neurosciences, computational and systems biology, and plant and microbial biosciences. Animated by the principle that the most impactful science is often achieved at the boundaries between disciplines, DBBS emphasizes breaking down academic silos and providing students with opportunities to apprentice in a wide variety of labs. More than 600 graduate students currently are training with faculty from more than 30 departments across the university.   “I am so pleased that Steve will continue to contribute his exceptional leadership and experience to DBBS,” said Feng Sheng Hu, the Richard G. Engelsmann Dean of Arts & Sciences and the Lucille P. Markey Distinguished Professor. “Much of the division’s incredible impact can be traced to its founding ideal of convergence and its focus on transdisciplinary collaboration — values echoed by the strategic vision of Arts & Sciences. Steve is committed to finding new ways to push disciplinary boundaries and to develop the pioneering scholars and research needed for biological and biomedical breakthroughs.” As director of DBBS, Mennerick aims to create more interdisciplinary coursework; encourage the development of meta skills such as critical thinking, creative problem-solving and flexibility; and improve methods for evaluating and tracking students’ progress. He also plans to enhance the student support infrastructure to help trainees weather the inevitable failures and challenges of graduate school. “Nature does not reveal its secrets willingly, and this can have an especially heavy emotional toll on graduate students,” Mennerick said. “We aim to support all students with innovative programming at each stage of their graduate careers, including bolstering affinity groups, offering mentorship training for DBBS-affiliated faculty and providing career-development opportunities for students interested in careers inside and outside of academia. We are serious about the advantages of enrolling students with diverse identities to foster creativity and innovation, but mindful that being a member of an underrepresented group may lead to a sense of isolation that can undermine the quality of the graduate experience if not addressed. Building appropriate support networks will enhance the graduate experience for all students and strengthen the next generation of bioscience leaders.” DBBS also serves as a pipeline for undergrads interested in pursuing advanced degrees in the biological and medical sciences. It hosts an Amgen Scholars Program, which prepares undergraduates to apply to top-tier graduate and professional schools through an intensive summer laboratory experience, as well as new Vagelos Undergraduate Research Fellowships for current Washington University undergrads, which couple a spring course with summer laboratory research under the mentorship of Washington University faculty. A 1995 graduate of DBBS, Mennerick studies how messages are sent between neurons and how dysfunction in this signaling can lead to mental disorders. His focus is on GABA receptors, molecules that are on the surface of neurons and play an important role in regulating emotion, cognition, pain, sleep and movement. GABA receptors have been linked to brain conditions including epilepsy, autism, depression and schizophrenia. They come in many subtypes, and Mennerick aims to understand the unique roles different subtypes play in the brain. His current work explores the advantages of chemical compounds known as neurosteroids to target certain GABA receptors as drug treatments for depression. “I came to DBBS as a student in large part because of the flexibility of training and outstanding administrative support, and as associate dean, I continue to maintain those two goals,” Mennerick continued. “During the interim period, I have been fortunate to interact with many dedicated administrators, faculty, staff and students who have infused incredible creativity and innovation into the training model. The continued insights and ideas of the great DBBS team, along with the ongoing support from upper administration, is what keeps DBBS on the cutting edge of biosciences training.” The division celebrated its 50th anniversary earlier this year. Founded in 1973 by P. Roy Vagelos, MD, then the head of the Department of Biological Chemistry, and then-Chancellor William H. Danforth, MD, the division pioneered a model for interdisciplinary education in the life sciences that has been widely copied. In memory of Danforth, who died in 2020 at the age of 94, Roy Vagelos and his wife, Diana Vagelos, have made a $15 million gift to the division to fund undergraduate programs and graduate student fellowships in the life sciences. SHARE Media Contact  Susan Killenberg McGinn TopicsAppointments & PromotionsCampus & CommunityMedicine Schools Arts & SciencesRead more stories from Arts & SciencesVisit Arts & SciencesSchool of MedicineRead more stories from School of MedicineVisit School of Medicine Leave a Comment Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum. You Might Also Like New antidepressants on horizon October 28, 2019 Published In Newsroom Stories Kim named inaugural Danforth WashU Physician-Scientist Scholar March 7, 2022 Published In Newsroom Stories Race-based variations in gut bacteria emerge by 3 months of age August 17, 2023 Published In Newsroom Stories Latest from the Newsroom Recent Stories Reframing voting as ‘duty to others’ key to increasing engagement, turnout Modifying homes for stroke survivors saves lives, extends independence Book explores consequences of political conversations WashU Experts Ten Commandments display probably not legal Social workers key to psychedelic-assisted therapies DeFake tool protects voice recordings from cybercriminals WashU in the News NFL faces ‘Sunday Ticket’ lawsuit: Here’s what’s at stake for the league Transcript: Ezra Klein Interviews Yanna Krupnikov The brain has a waste removal system and scientists are figuring out how it works Publications Washington Magazine Newsroom Record Explore Bookshelf Video Gallery Connect Media Resources Contact Facebook Instagram ©2024 Washington University in St. Louis Go back to top